# ARVYS Proteins (United States) > organization **Wikidata**: [Q100955868](https://www.wikidata.org/wiki/Q100955868) **Source**: https://4ort.xyz/entity/arvys-proteins-united-states ## Summary ARVYS Proteins is a business organization headquartered in Trumbull, Connecticut, United States, founded in 2005. The company operates in the protein research and development sector, providing products and services related to protein analysis, synthesis, and characterization. As a United States-based entity, it contributes to the country's biotechnology and life sciences industry, operating within the broader framework of American commercial, industrial, and professional activities. ## Key Facts - **Official Name:** ARVYS Proteins - **Country:** United States - **Inception:** 2005 - **Headquarters Location:** Trumbull, Connecticut - **Geographic Coordinates:** 41.296338°N, -73.231372°W - **Entity Type:** Business (organization undertaking commercial, industrial, or professional activity) - **Website:** https://www.arvysproteins.com/ - **ISNI:** 0000000492861229 - **ROR ID:** 05pet9r93 - **GRID ID:** grid.508542.e - **ScienceLit Organization ID:** 98146 - **Crunchbase Organization ID:** arvys-proteins-inc - **Wikidata Description:** Organization ## FAQs **What type of organization is ARVYS Proteins?** ARVYS Proteins is classified as a business—a legal entity engaged in commercial, industrial, or professional activities. It is an instance of a business organization and operates within the United States' economic framework. The business is legally classified as a juridical person, allowing it to engage in commercial transactions, own property, and enter into contracts. **Where is ARVYS Proteins located?** ARVYS Proteins is headquartered in Trumbull, Connecticut, United States. Trumbull is a town situated in Fairfield County, Connecticut, located at coordinates 41.296338°N latitude and -73.231372°W longitude. The company operates within the United States, the world's largest national economy by nominal GDP. **When was ARVYS Proteins founded?** ARVYS Proteins was founded in 2005. The company has been operating for nearly two decades, contributing to the biotechnology and life sciences sectors within the United States. **What industry does ARVYS Proteins operate in?** ARVYS Proteins operates in the protein research and development sector, focusing on protein-related products and services. This places it within the broader biotechnology and life sciences industry, which is a significant component of the United States' economic landscape. The United States leads globally in biotechnology innovation, pharmaceutical development, and medical research. **What identifiers are associated with ARVYS Proteins?** ARVYS Proteins is identified by multiple persistent identifiers across global knowledge systems: ISNI (0000000492861229), ROR ID (05pet9r93), GRID ID (grid.508542.e), ScienceLit Organization ID (98146), and Crunchbase Organization ID (arvys-proteins-inc). These identifiers enable cross-referencing across academic databases, research repositories, and business information platforms. ## Why It Matters ARVYS Proteins matters as a participant in the United States' biotechnology sector, which represents one of the nation's most innovative and economically significant industries. Founded in 2005, the company has contributed to protein research and development—a field critical to advancing medical treatments, diagnostic tools, and therapeutic interventions. The United States biotechnology sector is characterized by intensive research and development spending, with the country leading globally in pharmaceutical innovation and drug development. The company's location in Trumbull, Connecticut, positions it within a region known for its concentration of pharmaceutical companies, biotechnology firms, and research institutions. Fairfield County and the broader Connecticut area host numerous life sciences companies, creating a collaborative ecosystem for innovation in protein-related research. As a United States-based business, ARVYS Proteins operates within the world's largest economy, which serves as a global hub for technological advancement, financial activity, and commercial innovation. The United States' economic framework—characterized by strong property rights, a developed financial system, and extensive venture capital activity—provides an environment conducive to company growth and scientific advancement. The biotechnology industry in which ARVYS Proteins operates addresses some of humanity's most pressing health challenges, including disease treatment, vaccine development, and diagnostic innovation. Companies in this sector play crucial roles in advancing human health outcomes and addressing global medical needs. ## Notable For - **Specialized Focus:** Operating specifically in the protein research and development sector, contributing to a specialized area of biotechnology critical for medical and scientific advancement - **Connecticut Presence:** Located in Trumbull, Connecticut, within a region boasting significant concentrations of pharmaceutical and biotechnology companies - **Persistent Identifiers:** Maintains multiple unique identifiers across global knowledge systems, facilitating academic and commercial cross-referencing - **Established History:** Operating since 2005, representing nearly two decades of continuous operation in the competitive biotechnology sector - **Digital Presence:** Maintains an active web presence through https://www.arvysproteins.com/, enabling global accessibility to company information and services ## Body ### Classification and Legal Status ARVYS Proteins is classified as a business organization, which the United States legal framework defines as an organization undertaking commercial, industrial, or professional activity. As a business, it is considered a juridical person—a legal entity capable of entering into contracts, owning property, and engaging in commercial transactions. This classification places it within the broader category of economic entities that drive commercial activity within the United States economy. The business operates as a commercial organization engaged in activities related to protein research, development, and production. This places it within the biotechnology sector, which encompasses companies focused on using biological processes to develop products and technologies for healthcare, agriculture, and industrial applications. ### Geographic Context The company is headquartered in Trumbull, Connecticut, a town located in Fairfield County in the southwestern region of Connecticut. Trumbull is situated at coordinates 41.296338°N latitude and -73.231372°W longitude, placing it within the greater New York metropolitan area. This geographic positioning provides access to a dense network of research institutions, pharmaceutical companies, and biotechnology firms that characterize the Northeast corridor of the United States. Connecticut hosts a significant concentration of biotechnology and pharmaceutical companies, with the state's economy benefiting from its proximity to major research universities, hospitals, and the financial resources of the greater New England region. The state's business environment is supported by strong intellectual property protections, a skilled workforce, and access to venture capital—factors that contribute to the success of biotechnology companies operating within its borders. The United States, where ARVYS Proteins is located, represents the world's largest economy, with a nominal GDP that exceeds $28 trillion. The country serves as a global center for technological innovation, financial activity, and commercial enterprise, providing a supportive environment for companies operating in knowledge-intensive industries such as biotechnology. ### Historical Background ARVYS Proteins was founded in 2005, entering the biotechnology sector during a period of significant growth in the life sciences industry. The early 2000s saw substantial investment in biotechnology research, driven by advances in genomics, proteomics, and molecular biology. The company's establishment in 2005 reflects the broader expansion of the biotechnology sector during this period, as scientific breakthroughs created new opportunities for companies focused on protein-related research and development. ### Industry Context ARVYS Proteins operates within the biotechnology sector, an industry characterized by intensive research and development activity, significant capital investment, and long product development cycles. The biotechnology industry in the United States is recognized globally for its innovation, with American companies leading in pharmaceutical development, medical device innovation, and therapeutic advancement. The protein research and development field in which ARVYS Proteins operates addresses fundamental questions in biology and medicine. Proteins serve as the primary functional molecules in biological systems, and understanding their structure, function, and interactions is essential for developing new therapeutics, diagnostic tools, and agricultural products. Companies in this sector contribute to advancing human health through research into protein-based drugs, biomarkers, and therapeutic interventions. ### Organizational Identifiers ARVYS Proteins maintains a comprehensive set of persistent identifiers that enable identification and cross-referencing across multiple knowledge systems: - **ISNI (International Standard Name Identifier):** 0000000492861229—a globally unique identifier for public identities across creative industries - **ROR (Research Organization Registry) ID:** 05pet9r93—an identifier for research organizations enabling disambiguation and linking across scholarly infrastructure - **GRID ID:** grid.508542.e—a unique identifier for research organizations used in academic databases - **ScienceLit Organization ID:** 98146—an identifier used in scientific literature databases - **Crunchbase Organization ID:** arvys-proteins-inc—an identifier in the business intelligence platform Crunchbase These identifiers facilitate the company's integration into global knowledge graphs, enabling researchers, investors, and business partners to locate and reference the organization across multiple platforms and databases. ### Digital Presence ARVYS Proteins maintains an online presence through its website at https://www.arvysproteins.com/. This digital presence enables the company to communicate with potential customers, partners, and the broader scientific community. In the biotechnology sector, online presence is essential for reaching international markets, showcasing product offerings, and facilitating scientific collaboration. ### Relationship to Broader Knowledge Systems ARVYS Proteins, as a business organization, relates to the broader concept of "business" as defined in knowledge classification systems. The business classification encompasses organizations engaged in commercial, industrial, or professional activities, with the primary goal of generating profit or economic value. This classification system, managed through initiatives such as WikiProject Companies, provides a framework for understanding the role of organizations like ARVYS Proteins within the global economy. The company exists within a knowledge ecosystem that includes library classification systems, semantic web identifiers, and academic databases. This interconnected system enables the organization to be referenced, researched, and analyzed across multiple platforms, contributing to the broader understanding of commercial activity within the biotechnology sector. ## References 1. GRID release 2020-10-06 2. ROR Data Dump 6.0 (October 2020)